Opy Acquisition Corp. I
opyacquisitioncorp.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2023 10-Q, filed Nov 8, 2023. Its latest SEC filing is a SC 13G/A from Feb 12, 2024.
10-Q for Q3 FY2023, filed Nov 8, 2023
The sections below describe the company as of the FY2022 annual report.
What Did They Do?
Seeks a merger or similar transaction with a business, focusing on life sciences targets developing therapeutics, medical devices or healthcare services.
10-K for FY2022, filed Mar 17, 2023
How Did They Make Money?
No revenue was reported.
10-K for FY2022, filed Mar 17, 2023
How Were They Changing?
- Net income
-
Sources
10-Q for Q3 FY2023, filed Nov 8, 2023
−$121.8KView ↗
- ▼ Now a loss
- vs $158.4K in Q3 FY2022
-
Dec 20, 2023
Plans to dissolve and liquidate after failing to complete a business combination
Public shares will be cancelled and redeemed; warrants receive no liquidation distributions.
Sources
8-K, filed Dec 20, 2023
On December 18, 2023, OPY Acquisition Corp. I (the “Company”) issued a press release announcing that it will be unable to consummate an…View ↗
Loading...
